[HTML][HTML] Platelet counting: ugly traps and good advice. Proposals from the French-Speaking Cellular Hematology Group (GFHC)

V Baccini, F Geneviève, H Jacqmin… - Journal of clinical …, 2020 - mdpi.com
Despite the ongoing development of automated hematology analyzers to optimize complete
blood count results, platelet count still suffers from pre-analytical or analytical pitfalls …

Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience

S Park, S Grabar, C Kelaidi… - Blood, The Journal …, 2008 - ashpublications.org
We analyzed prognostic factors of response, response duration, and possible impact on
survival of epoetin α, epoetin β, or darbepoetin α (DAR) with or without granulocyte colony …

Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia

L Willems, N Jacque, A Jacquel… - Blood, The Journal …, 2013 - ashpublications.org
Cancer cells require nutrients and energy to adapt to increased biosynthetic activity, and
protein synthesis inhibition downstream of mammalian target of rapamycin complex 1 …

Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute …

J Tamburini, N Chapuis, V Bardet… - Blood, The Journal …, 2008 - ashpublications.org
The phosphatidylinositol 3-kinase (PI3K)/Akt and mTORC1 pathways are frequently
activated, representing potential therapeutic targets in acute myeloid leukemia (AML). In 19 …

Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia

D Selimoglu-Buet, O Wagner-Ballon… - Blood, The Journal …, 2015 - ashpublications.org
Chronic myelomonocytic leukemia (CMML) is a myelodysplastic syndrome/
myeloproliferative neoplasm whose diagnosis is currently based on the elevation of …

Constitutive phosphoinositide 3-kinase/Akt activation represents a favorable prognostic factor in de novo acute myelogenous leukemia patients

J Tamburini, C Elie, V Bardet, N Chapuis… - Blood, The Journal …, 2007 - ashpublications.org
Abstract The phosphoinositide 3-kinase (PI3K/Akt) pathway is activated in acute
myelogenous leukemia (AML) and is promising for targeted inhibition. Ninety-two patients …

A critical role for Lyn in acute myeloid leukemia

C Dos Santos, C Demur, V Bardet… - Blood, The Journal …, 2008 - ashpublications.org
Receptor or nonreceptor tyrosine kinases (TKs) are known to play an important role in
leukemogenesis. Here we studied the level of protein tyrosine phosphorylations in a series …

[HTML][HTML] Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R …

N Chapuis, J Tamburini, P Cornillet-Lefebvre… - …, 2010 - ncbi.nlm.nih.gov
Background Alterations in the PI3K/Akt pathway are found in a wide range of cancers and
the development of PI3K inhibitors represents a promising approach to cancer therapy …

How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?

F Garnache-Ottou, C Vidal, S Biichlé, F Renosi… - Blood …, 2019 - ashpublications.org
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia for
which we developed a nationwide network to collect data from new cases diagnosed in …

Full blood count normal reference values for adults in France

X Troussard, E Cornet, V Bardet, JP Couaillac… - Journal of clinical …, 2014 - jcp.bmj.com
Aims To determine full blood count (FBC) normal reference values for adults. Methods FBC
normal values for healthy adults were defined, after establishing preanalytical conditions, in …